The company's low ROE and stagnant net income growth are unappealing. Despite high profit retention, the low ROE indicates that investors may not be reaping the benefits. The recent decision to pay dividends may signal a change in management's approach to shareholder returns.
西点药业股票讨论区
暂无评论